Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 70, Issue 4 , Pages 391-397 , April 2004

Eicosapentaenoic acid and gamma-linolenic acid increase hippocampal concentrations of IL-4 and IL-10 and abrogate lipopolysaccharide-induced inhibition of long-term potentiation

,Accepted 18 December 2003.

References 

  1. Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, et al. Brain interleukin-1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. 1989;86:7611–7615
  2. Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M, et al. Interleukin-1 beta, interleukin-6 epidermal growth factor and transforming growth factor-alpha are elevated in the brain from Parkinsonian patients. Neurosci. Lett. 1994;180:147–150
  3. McGeer PL, McGeer EG. The inflammatory response system of brain (implications for therapy of Alzheimer and other neurodegenerative diseases). Brain Res. Rev. 1995;21:195–218
  4. McGeer PL, McGeer EG. Local neuroinflammation and the progression of Alzheimer's disease. J. Neurovirol. 2002;8:529–538
  5. Mrak RE, Sheng JG, Griffin WS. Glial cytokines in Alzheimer's disease (review and pathogenic implications). Human Pathol. 1995;26:816–823
  6. Loscher CE, Donnelly S, Mills KHG, Lynch MA. Interleukin-1β-dependent changes in hippocampal function following immunization with a whole cell pertussis vaccine. J. Neuroimmunol. 2000;11:68–76
  7. Vereker E, Campbell V, Roche E, McEntee E, Lynch MA. Lipopolysaccharide inhibits long-term potentiation in the rat dentate gyrus by activating caspase-1. J. Biol. Chem. 2000;275:26252–26528
  8. Pugh CR, Kumagawa K, Fleshner M, Watkins LR, Maier SF, Rudy JW. Selective effects of peripheral lipopolysaccharide administration on contextual and auditory-cue fear conditioning. Brain Behav. Immun. 1998;12:212–229
  9. Hauss-Wegrzyniak B, Vraniak P, Wenk G. The effects of a novel NSAID on chronic neuroinflammation are age dependent. Neurobiol. Aging. 1999;20:305–313
  10. Shaw KN, Commins S, O’Mara SM. Lipopolysaccharide causes deficits in spatial learning in the watermaze but not in BDNF expression in the rat dentate gyrus. Behav. Brain Res. 2001;124:47–54
  11. Lynch AM, Walsh C, Delaney A, Nolan Y, Campbell VA, Lynch MA. Lipopolysaccharide-induced increase in signallig in hippocampus is abrogated by IL-10—a role for IL-1β?. J. Neurochem. 2004;88:635–646
  12. Bluthe RM, Castanon N, Pousset F, Bristow A, Ball C, Lestage J, et al. Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats. Psychoneuroendocrinology. 1999;24:301–311
  13. Murray C, Lynch MA. Evidence that increased hippocampal expression of the cytokine, IL-1β, is a common trigger for age and stress-induced impairments in long-term potentiation. J. Neurosci. 1998;18:2974–2981
  14. McGahon BM, Murray CA, Horrobin DF, Lynch MA. Age-related changes in oxidative mechanisms and LTP are reversed by dietary manipulation. Neurobiol. Aging. 1999;20:643–653
  15. Martin DS, Lonergan PE, Boland B, Fogarty MP, Brady M, Horrobin DF, et al. Apoptotic changes in the aged brain are triggered by interleukin-1beta-induced activation of p38 and reversed by treatment with eicosapentaenoic acid. J. Biol. Chem. 2002;277:34239–34246
  16. Barnes CA. Memory deficits associated with senescence (a neurophysiological and behavioural study in the rat). J. Comp. Physiol. Psych. 1979;93:74–104
  17. Barnes CA. Spatial learning and memory processes (the search for their neurobiological mechanisms in the rat). TINS. 1988;11:163–169
  18. Diana G, Scotti De Carolis A, Frank C, Domenici MR, Sagratella S. Selective reduction of hippocampal dentate frequency potentiation in aged rats with impaired place learning. Brain Res. Bull. 1994;35:107–111
  19. Lynch MA. Interleukin-1 beta exerts a myriad of effects in the brain and in particular in the hippocampus (analysis of some of these actions). Vitam. Horm. 2002;64:185–219
  20. O’Donnell E, Vereker E, Lynch MA. Age-related impairment in LTP is accompanied by enhanced activity of stress-activated protein kinases (analysis of underlying mechanisms). Eur. J. Neurosci. 2000;12:345–352
  21. Minogue AM, Schmid AW, Fogarty MF, Moore AC, Campbell VA, Herron CE. Activation of the JNK signalling cascade mediates the effect of Aβ on LTP and cell death in hippocampus (a role for IL-1β). J. Biol. Chem. 2003;278:27971–27980
  22. Babcock T, Helton WS, Espat NJ. Eicosapentanoic acid (EPA) (an anti-inflammatory ω-3 fat with potential clinical applications). Nutrition. 2000;16:1116–1118
  23. McCarthy MF. Vascular nitric oxide, sex hormone replacement, and fish oil may help to prevent Alzheimer's Disease by suppressing synthesis of acute-phase cytokines. Med. Hypotheses. 1999;53:369–374
  24. Wallace FA, Miles EA, Calder PC. Activation state alters the effect of dietary fatty acids on pro-inflammatory mediator production by murine macrophages. Cytokine. 2000;12:1374–1379
  25. Calder PC, Zurier RB. Polyunsaturated fatty acids and rheumatoid arthritis. Curr. Opin. Clin. Nutr. Metab. Care. 2001;4:115–121
  26. Kainu T, Wikstrom AC, Gustafsson JA, Pelto-Huikko M. Localization of the peroxisome proliferator-activated receptor in the brain. Neuroreport. 1994;5:2481–2485
  27. Berger J, Moller DE. The mechanisms of action of PPARs. Annu. Rev. Med. 2002;53:409–435
  28. Bernardo A, Levi G, Minghetti L. Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions. Eur. J. Neurosci. 2000;12:2215–2223
  29. Kim EJ, Kwon KJ, Park JY, Lee SH, Moon CH, Baik EJ. Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons (associated with iNOS and COX-2). Brain Res. 2002;941:1–10
  30. Petrova TV, Akama KT, Van Eldik LJ. Cyclopentenone prostaglandins suppress activation of microglia (down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2). Proc. Natl. Acad. Sci. 1999;96:4668–4673
  31. Lonergan PE, Martin DSD, Horrobin DF, Lynch MA. Neuroprotective effect of eicosapentanoate in hippocampus of rats exposed to Gamma irradiation. J. Biol. Chem. 2002;277:20804–20811
  32. Haan EA, Bowen DM. Protection of neocortical prisms from freeze-thaw injury by dimethylsulphoxide. J. Neurochem. 1981;37:243–246
  33. Nolan Y, Minogue A, Vereker E, Bolton AE, Campbell VA, Lynch MA. Attenuation of LPS-induced changes in synaptic activity in rat hippocampus by Vasogen's immune modulation therapy. Neuroimmunomodulation. 2002;10:40–46
  34. Bellinger FP, Madamba S, Siggins GR. Interleukin-1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res. 1993;628:227–234
  35. Cunningham AJ, Murray CA, O’Neill LAJ, Lynch MA, O’Connor JJ. Interleukin-1β (IL-1β) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci. Lett. 1996;203:1–4
  36. Katsuki H, Nakai S, Hirai Y, Akaji K, Kiso Y, Satoh M. Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur. J. Pharmacol. 1990;181:323–326
  37. Lonergan PE, Martin DSD, Horrobin DF, Lynch MA. Neuroprotective effect of eicosapentanoate in hippocampus of rats exposed to Gamma irradiation. FENS Abstract. 2002;1:A048.8
  38. Hayashi H, Tanaka Y, Hibino H, Umeda Y, Kawamitsu H, Fujimoto H, et al. Beneficial effect of salmon roe phosphatidylcholine in chronic liver disease. Curr. Med. Res. Opin. 1999;15:177–184
  39. Curtis CL, Hughes CE, Flannery CR, Little CB, Harwood JL, Caterson B. n-3 Fatty acids specifically modulate catabolic factors involved in articular cartilage degradation. J. Biol. Chem. 2000;275:721–724
  40. Sadeghi S, Wallace FA, Calder PC. Dietary lipids modify the cytokine response to bacterial lipopolysaccharide in mice. Immunology. 1999;96(3):404–410
  41. Chambrier C, Bastard JP, Rieusset J, Chevillotte E, Bonnefont-Rousselot D, Therond P, et al. Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma. Obes Res. 2002;10:518–525
  42. Janabi N. Selective inhibition of cyclooxygenase-2 expression by 15-deoxy-Delta(12,14)(12,14)-prostaglandin J(2) in activated human astrocytes* but not in human brain macrophages. J Immunol. 2002;168:4747–4755
  43. Nolan, Y., Vereker, E., Lynch, M.A., Evidence that accumulation of reactive oxygen species and activation of p38 mediates lipopolysaccharide-induced cell death in rat hippocampus, J. Physiol. 551.P (2003) C69 46P.
  44. Kitamura Y, Taniguchi T, Kimura H, Nomura Y, Gebicke-Haerter PJ. Interleukin-4-inhibited mRNA expression in mixed rat glial and in isolated microglial cultures. J. Neuroimmunol. 2000;106:95–104
  45. Ledeboer A, Breve JJ, Wierinckx A, Van der Jagt S, Bristow AF, Leysen JE, et al. Expression and regulation of interleukin-10 and interleukin-10 receptor in rat astroglial and microglial cells. Eur. J. Neurosci. 2002;16:1175–1185
  46. Molina-Holgado E, Vela JM, Arevalo-Martin A, Guaza C. LPS/IFN-gamma cytotoxicity in oligodendroglial cells (role of nitric oxide and protection by the anti-inflammatory cytokine IL-10). Eur. J. Neurosci. 2001;13:493–502
  47. Szczepanik AM, Funes S, Petko W, Ringheim GE. IL-4, IL-10 and IL-13 modulate A beta(1–42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line. J. Neuroimmunol. 2001;113:49–62
  48. Kelly Á, Lynch A, Vereker E, Nolan Y, Queenan P, Whittaker E, et al. The anti-inflammatory cytokine, IL-10, blocks the inhibitory effect of IL-1β on LTP (a role for JNK). J. Biol. Chem. 2001;276:45564–45572

PII: S0952-3278(04)00011-0

doi: 10.1016/j.plefa.2003.12.014

Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 70, Issue 4 , Pages 391-397 , April 2004

Article Tools

* Image Usage & Resolution